Inactive Instrument

News SEMR PARA Nasdaq

Equities

LGSTU

KYG8028L1234

Summary

Unlock all the news: Be the first to know and act before the market!

Semper Paratus Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
SEMR PARA : Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments - Form 8-K	26/04	PU
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN	15/02	AQ
Semper Paratus Acquisition Corporation(NasdaqGM:LGST) dropped from NASDAQ Composite Index	14/02	CI
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in a reverse merger transaction.	14/02	CI
Semper Paratus Acquisition Shareholders Approve Tevogen Bio Deal	02/02	MT
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio	01/02	AQ
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq	25/01	AQ
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination	05/01	AQ
Semper Paratus Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K	18/12	PU
Semper Paratus Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement	29/23/29	AQ
Semper Paratus Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22	CI
Semper Paratus Acquisition to Merge With Tevogen Bio; to Bring Tevogen Public	29/23/29	MT
Biotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listing	29/23/29	RE
Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal	29/23/29	RE
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation	29/23/29	AQ
Tevogen Bio Inc entered into a merger agreement to acquire Semper Paratus Acquisition Corporation for $1.5 billion in a reverse merger transaction.	29/23/29	CI
Insider Sell: Semper Paratus Acquisition	08/23/08	MT
SEMPER PARATUS ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	08/23/08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SEMR PARA Nasdaq

Equities

LGSTU

KYG8028L1234

Summary

Filters